ARID3B
Basic information
Region (hg38): 15:74541206-74598131
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ARID3B gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 3 | |||||
missense | 20 | 21 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 20 | 1 | 3 |
Variants in ARID3B
This is a list of pathogenic ClinVar variants found in the ARID3B region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
15-74543949-C-G | not specified | Uncertain significance (May 11, 2022) | ||
15-74543985-C-G | not specified | Uncertain significance (May 09, 2024) | ||
15-74543987-G-C | not specified | Uncertain significance (Mar 15, 2024) | ||
15-74544097-C-T | not specified | Uncertain significance (Feb 16, 2023) | ||
15-74544324-C-G | not specified | Uncertain significance (Dec 01, 2022) | ||
15-74544333-A-G | not specified | Uncertain significance (Sep 30, 2024) | ||
15-74544375-C-T | not specified | Uncertain significance (Sep 17, 2021) | ||
15-74544411-A-G | not specified | Uncertain significance (Jan 09, 2024) | ||
15-74544426-G-A | not specified | Uncertain significance (Jan 23, 2024) | ||
15-74544433-C-T | not specified | Uncertain significance (Jun 18, 2021) | ||
15-74544439-T-C | not specified | Uncertain significance (Sep 25, 2024) | ||
15-74572877-T-C | not specified | Uncertain significance (Jul 13, 2022) | ||
15-74572931-A-G | not specified | Uncertain significance (Apr 08, 2023) | ||
15-74573186-G-A | not specified | Likely benign (Feb 11, 2022) | ||
15-74589834-C-A | Benign (Nov 15, 2017) | |||
15-74589911-G-A | Benign (Jan 05, 2018) | |||
15-74591251-C-T | not specified | Uncertain significance (Oct 04, 2022) | ||
15-74591254-C-T | not specified | Uncertain significance (May 02, 2024) | ||
15-74591311-G-A | not specified | Uncertain significance (Oct 29, 2024) | ||
15-74591317-G-A | not specified | Uncertain significance (Oct 25, 2022) | ||
15-74591318-G-C | not specified | Uncertain significance (Oct 03, 2022) | ||
15-74591598-C-T | not specified | Uncertain significance (May 16, 2022) | ||
15-74591623-C-G | not specified | Uncertain significance (Mar 30, 2024) | ||
15-74591643-C-G | not specified | Uncertain significance (Oct 20, 2023) | ||
15-74591649-G-A | not specified | Uncertain significance (Sep 10, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ARID3B | protein_coding | protein_coding | ENST00000346246 | 8 | 56955 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.380 | 0.620 | 125738 | 0 | 10 | 125748 | 0.0000398 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.27 | 267 | 332 | 0.804 | 0.0000193 | 3610 |
Missense in Polyphen | 81 | 127.97 | 0.63294 | 1383 | ||
Synonymous | -0.629 | 142 | 133 | 1.07 | 0.00000789 | 1166 |
Loss of Function | 3.39 | 5 | 22.3 | 0.224 | 0.00000110 | 254 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000302 | 0.0000302 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000114 | 0.000109 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.0000363 | 0.0000352 |
Middle Eastern | 0.000114 | 0.000109 |
South Asian | 0.0000985 | 0.0000653 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Transcription factor which may be involved in neuroblastoma growth and malignant transformation. Favors nuclear targeting of ARID3A. {ECO:0000269|PubMed:16951138, ECO:0000269|PubMed:17400556}.;
Recessive Scores
- pRec
- 0.106
Intolerance Scores
- loftool
- 0.369
- rvis_EVS
- -0.22
- rvis_percentile_EVS
- 37.43
Haploinsufficiency Scores
- pHI
- 0.266
- hipred
- Y
- hipred_score
- 0.728
- ghis
- 0.545
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.985
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Arid3b
- Phenotype
- nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); immune system phenotype; embryo phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); craniofacial phenotype; cellular phenotype; growth/size/body region phenotype;
Gene ontology
- Biological process
- biological_process;positive regulation of transcription by RNA polymerase II
- Cellular component
- nucleus;nucleoplasm
- Molecular function
- RNA polymerase II regulatory region sequence-specific DNA binding;RNA polymerase II proximal promoter sequence-specific DNA binding;RNA polymerase II distal enhancer sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription activator activity, RNA polymerase II-specific;DNA binding;protein binding